Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vulvar Neoplasms × Radiotherapy × Clear all

Status

Sponsor Class

Study Type

Interventional 8 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Head and Neck Neoplasms 15 Prostatic Neoplasms 12 Neoplasms 12 Lung Neoplasms 11 Radiation Injuries 8 Esophageal Neoplasms 8 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Rectal Neoplasms 5 Glioblastoma 5 Neoplasm Metastasis 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Central Nervous System Neoplasms 3 Astrocytoma 3 Xerostomia 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Pelvic Neoplasms 2 Osteoradionecrosis 2 Esthesioneuroblastoma, Olfactory 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Adenocarcinoma 2 Vulvar Neoplasms 1

Interventions

Surveys and Questionnaires 3 Surgical Procedures, Operative 2 trastuzumab deruxtecan 1 Watchful Waiting 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 RNA 1 Psychiatric Rehabilitation 1 Observation 1 Multimodal Imaging 1 Indocyanine Green 1 Immunohistochemistry 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Drug Therapy 1 DNA 1 Circulating Tumor DNA 1 CA-125 Antigen 1 Buthionine Sulfoximine 1 Brachytherapy 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02067052 2022-04-15

New Strategy for the Treatment of Vulvar Cancer

Instituto do Cancer do Estado de São Paulo

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡